Condition 1: Multiple sclerosis. Condition 2: Neurasthenia. Multiple sclerosis Neurasthenia
Conditions
Interventions
Intervention 1: Intervention group: Interferon (main treatment) with Milk thistle capsules (420 mg daily) for one month. Intervention 2: Control group: Interferon (main treatment) with placebo capsul
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 65 Years
Inclusion criteria
Inclusion criteria: Multiple sclerosis patients have fatigue Ages between 15-65 years old
Exclusion criteria
Exclusion criteria: other neurological disease Diseases like diabetes and autoimmune diseases new attack in the last month New disease attack Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue. Timepoint: Start intervention and a month later. Method of measurement: MFIS questionnaire.;Quality of Life. Timepoint: Start intervention and a month later. Method of measurement: MSQL-54 questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: One month after the intervention began. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Siahpoosh
Ahvaz University of Medical Sciences
Outcome results
None listed